{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T23:31:30Z","timestamp":1791502290706,"version":"4.3.4"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T00:00:00Z","timestamp":1659484800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>There is no method of predicting human cytomegalovirus (HCMV) outcomes in allogeneic hematopoietic stem cell transplant recipients clinically, leading in some cases to excessive or insufficient antiviral therapy. We evaluated the early immune response of recipients with disparate HCMV outcomes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>The HCMV outcomes of recipients were determined by long-term monitoring of HCMV DNA levels posttransplant. HCMV IgG and IgM concentrations at 1 week before and 1 week after transplantation, absolute lymphocyte counts, and HCMV-specific IFN-\u03b3 secreting cells at 1 month posttransplant were evaluated based on HCMV outcome.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>All recipients were negative for HCMV IgM. Significant differences between recipients with and without HCMV reactivation were observed in pre- and post-transplant HCMV IgG antibody levels, absolute lymphocyte counts, and HCMV-specific IFN-\u03b3 secreting cells (P &amp;lt; 0.05). HCMV IgG antibody levels significantly increased after transplantation in recipients with HCMV reactivation (P = 0.032), but not in those without reactivation. Multivariate analysis revealed that except for the absolute lymphocyte count these biomarkers were related to HCMV reactivation, independent of other clinical factors. In time-to-event analyses, lower levels of these biomarkers were associated with an increased 150-day cumulative incidence of HCMV reactivation (log-rank P &amp;lt; 0.05). In recipients with HCMV reactivation, the duration of HCMV DNAemia had negative correlation with HCMV-specific IFN-\u03b3-secreting cells (P = 0.015, r = -0.372). The relationships between the peak HCMV DNA load and absolute lymphocyte count and HCMV-specific IFN-\u03b3-secreting cells followed the same trends (P = 0.026, r = -0.181 and P = 0.010, r\u00a0= -0.317).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>HCMV IgG, absolute lymphocyte count, and HCMV-specific IFN-\u03b3 secreting cells represent the humoral and cellular immune response. Early monitoring of these immune markers could enable prediction of HCMV outcomes posttransplant and assessment of the severity of HCMV DNAemia.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.954420","type":"journal-article","created":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T05:14:55Z","timestamp":1659503695000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":2,"title":["Early immune surveillance to predict cytomegalovirus outcomes after allogeneic hematopoietic stem cell transplantation"],"prefix":"10.3389","volume":"12","author":[{"given":"Jintao","family":"Xia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuejie","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genyong","family":"Gui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengnan","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxin","family":"Shang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"10995","DOI":"10.1128\/JVI.78.20.10995-11006.2004","article-title":"Major human cytomegalovirus structural protein pp65 (ppUL83) prevents interferon response factor 3 activation in the interferon response","volume":"78","author":"Abate","year":"2004","journal-title":"J. Virol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1038\/sj.bmt.1702450","article-title":"Foscarnet prophylaxis of cytomegalovirus infections in patients undergoing allogeneic bone marrow transplantation (BMT): a dose-finding study","volume":"26","author":"Bregante","year":"2000","journal-title":"Bone Marrow Transplant."},{"key":"B3","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1016\/j.bbmt.2017.11.038","article-title":"Impact of cytomegalovirus viral load on probability of spontaneous clearance and response to preemptive therapy in allogeneic stem cell transplantation recipients","volume":"24","author":"Camargo","year":"2018","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B4","doi-asserted-by":"publisher","first-page":"7252","DOI":"10.1158\/1078-0432.CCR-04-0713","article-title":"X-Tile: a new bio-informatics tool for biomarker assessment and outcome-based cut-point optimization","volume":"10","author":"Camp","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1038\/srep19227","article-title":"Cytotoxic polyfunctionality maturation of cytomegalovirus-pp65-specific CD4 + and CD8 + T-cell responses in older adults positively correlates with response size","volume":"6","author":"Chiu","year":"2016","journal-title":"Sci. Rep."},{"key":"B6","doi-asserted-by":"publisher","first-page":"4771","DOI":"10.1182\/blood-2008-10-183723","article-title":"Haploidentical stem cell transplantation after a reduced-intensity conditioning regimen for the treatment of advanced hematologic malignancies: posttransplantation CD8-depleted donor lymphocyte infusions contribute to improve T-cell recovery","volume":"113","author":"Dodero","year":"2009","journal-title":"Blood"},{"key":"B7","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.1002\/ajh.25950","article-title":"Myelodysplastic syndromes: 2021 update on diagnosis, risk stratification and management","volume":"95","author":"Garcia-Manero","year":"2020","journal-title":"Am. J. Hematol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1128\/JCM.02571-13","article-title":"Early kinetics of plasma cytomegalovirus DNA load in allogeneic stem cell transplant recipients in the era of highly sensitive real-time PCR assays: does it have any clinical value","volume":"52","author":"Gimenez","year":"2014","journal-title":"J. Clin. Microbiol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.chom.2019.11.013","article-title":"Human cytomegalovirus miRNAs regulate TGF-beta to mediate myelosuppression while maintaining viral latency in CD34(+) hematopoietic progenitor cells","volume":"27","author":"Hancock","year":"2020","journal-title":"Cell Host Microbe"},{"key":"B10","doi-asserted-by":"publisher","first-page":"S109","DOI":"10.1093\/infdis\/jiz389","article-title":"The development of therapeutics for the treatment and prevention of CMV disease in the transplant population: A regulatory perspective","volume":"221","author":"Hodowanec","year":"2020","journal-title":"J. Infect. Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1051","DOI":"10.1182\/bloodadvances.2019000814","article-title":"Heterogeneous impact of cytomegalovirus reactivation on nonrelapse mortality in hematopoietic stem cell transplantation","volume":"4","author":"Kaito","year":"2020","journal-title":"Blood Adv."},{"key":"B12","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.idc.2018.04.008","article-title":"Prevention and treatment of cytomegalovirus infections in solid organ transplant recipients","volume":"32","author":"Koval","year":"2018","journal-title":"Infect. Dis. Clin. North Am."},{"key":"B13","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1469-0691.2007.01895.x","article-title":"Detection of cytomegalovirus reactivation in cancer patients receiving chemotherapy","volume":"14","author":"Kuo","year":"2008","journal-title":"Clin. Microbiol. Infect."},{"key":"B14","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1016\/j.jcv.2013.07.006","article-title":"Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-gamma-enzyme-linked immunospot assays","volume":"58","author":"Liu","year":"2013","journal-title":"J. Clin. Virol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"e260","DOI":"10.1016\/S1473-3099(19)30107-0","article-title":"Guidelines for the management of cytomegalovirus infection in patients with haematological malignancies and after stem cell transplantation from the 2017 European conference on infections in leukaemia (ECIL 7)","volume":"19","author":"Ljungman","year":"2019","journal-title":"Lancet Infect. Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.hoc.2010.11.011","article-title":"Cytomegalovirus in hematopoietic stem cell transplant recipients","volume":"25","author":"Ljungman","year":"2011","journal-title":"Hematol. Oncol. Clin. North Am."},{"key":"B17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1128\/CMR.00062-12","article-title":"The \"silent\" global burden of congenital cytomegalovirus","volume":"26","author":"Manicklal","year":"2013","journal-title":"Clin. Microbiol. Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1126\/science.aat0066","article-title":"Strain-specific antibody therapy prevents cytomegalovirus reactivation after transplantation","volume":"363","author":"Martins","year":"2019","journal-title":"Science"},{"key":"B19","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1111\/ajt.15764","article-title":"Outcomes of patients with detectable CMV DNA at randomization in the phase III trial of letermovir for the prevention of CMV infection in allogeneic hematopoietic cell transplantation","volume":"20","author":"Marty","year":"2020","journal-title":"Am. J. Transplant."},{"key":"B20","doi-asserted-by":"publisher","first-page":"1266","DOI":"10.1038\/s41409-020-01176-8","article-title":"Cytomegalovirus retinitis after allogeneic hematopoietic stem cell transplantation under cytomegalovirus antigenemia-guided active screening","volume":"56","author":"Mori","year":"2020","journal-title":"Bone Marrow Transplant"},{"key":"B21","doi-asserted-by":"publisher","first-page":"1602","DOI":"10.1016\/j.bbmt.2011.08.014","article-title":"Dynamics of cytomegalovirus (CMV) plasma DNAemia in initial and recurrent episodes of active CMV infection in the allogeneic stem cell transplantation setting: implications for designing preemptive antiviral therapy strategies","volume":"17","author":"Munoz-Cobo","year":"2011","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B22","doi-asserted-by":"publisher","first-page":"3690","DOI":"10.1182\/blood-2002-05-1387","article-title":"Cytomegalovirus reactivation following allogeneic stem cell transplantation is associated with the presence of dysfunctional antigen-specific CD8+ T cells","volume":"100","author":"Ozdemir","year":"2002","journal-title":"Blood"},{"key":"B23","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.antiviral.2018.05.006","article-title":"Analysis of spontaneous resolution of cytomegalovirus replication after transplantation in CMV-seropositive patients with pretransplant CD8+IFNG+ response","volume":"155","author":"Paez-Vega","year":"2018","journal-title":"Antiviral Res."},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcv.2020.104641","article-title":"Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. a French retrospective cohort study","volume":"132","author":"Perillaud-Dubois","year":"2020","journal-title":"J. Clin. Virol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1186\/s12985-020-01390-2","article-title":"Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes","volume":"17","author":"Shibamura","year":"2020","journal-title":"Virol. J."},{"key":"B26","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1186\/s12884-019-2360-1","article-title":"Serological screening of immunoglobulin m and immunoglobulin G during pregnancy for predicting congenital cytomegalovirus infection","volume":"19","author":"Torii","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"B27","doi-asserted-by":"publisher","first-page":"128ra142","DOI":"10.1126\/scitranslmed.3003647","article-title":"T Cell receptor alphabeta diversity inversely correlates with pathogen-specific antibody levels in human cytomegalovirus infection","volume":"4","author":"Wang","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1155\/2020\/6027361","article-title":"Th1\/Th2 cells and associated cytokines in acute hepatitis e and related acute liver failure","volume":"2020","author":"Wu","year":"2020","journal-title":"J. Immunol. Res."},{"key":"B29","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12979-018-0120-0","article-title":"Anti-cytomegalovirus IgG antibody titer is positively associated with advanced T cell differentiation and coronary artery disease in end-stage renal disease","volume":"15","author":"Yang","year":"2018","journal-title":"Immun. Ageing"},{"key":"B30","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1038\/s41598-020-80790-4","article-title":"Post-transplant absolute lymphocyte count predicts early cytomegalovirus infection after heart transplantation","volume":"11","author":"Yoon","year":"2021","journal-title":"Sci. Rep."},{"key":"B31","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1002\/ajh.26270","article-title":"Aggressive T-cell lymphomas: 2021 updates on diagnosis, risk stratification and management","volume":"96","author":"Zain","year":"2021","journal-title":"Am. J. Hematol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.cellimm.2018.12.011","article-title":"Specific T-cell receptor gene transfer enhances immune response: A potential therapeutic strategy for the control of human cytomegalovirus infection in immunocompromised patients","volume":"336","author":"Zhang","year":"2019","journal-title":"Cell Immunol."},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/rmv.2034","article-title":"Estimation of the worldwide seroprevalence of cytomegalovirus: A systematic review and meta-analysis","volume":"29","author":"Zuhair","year":"2019","journal-title":"Rev. Med. Virol."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.954420\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,8,3]],"date-time":"2022-08-03T05:14:58Z","timestamp":1659503698000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.954420\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,3]]},"references-count":33,"alternative-id":["10.3389\/fcimb.2022.954420"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.954420","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,8,3]]},"article-number":"954420"}}